$GCAN Patented Dosage System and Cannabis Dream Team of Execs

OTC:GCAN   Greater Cannabis Co Inc
$GCAN has now Landed The former CEO of a billion dollar multi-national Company, and a distinguished scientist along with 7 others:

Aitan Zacharin - $GCAN's new CEO identified and hired executive talent to lead the commercialization strategy including the past President of SC Johnson Company and previous CEO of Champs and Footlocker Sports. He successfully led the company to raise over $10M in three over-subscribed rounds, as well as negotiated contracts with 26 world renowned athlete and celebrity brand ambassadors, which included top ranked pro golfer Tiger Woods.

Mark Radom - $GCAN NEW Legal COUNSEL worked on Wall Street and in the City of London as a US securities and capital markets lawyer where he represented sovereigns, global investment banks and fortune 500 companies across a broad range of capital raising and corporate transactions.

David Tavor - Chairman of the Board of Pharmedica and now the Managing Director of $GCAN

Dr . Hock Tan - GCAN's new Chairman of Scientific Advisory Board

Elisha Kalfa - Chief Operating Officer at North American Dental

Joe Kalfa - Founder - North American Dental with 50 employees world Wide with over 2800 Followers
Dentist just like Doctors can write RX prescription and what will GCAN's Green C owner of a Exclusive World Wide License for an orally dissolved film containing Cannabis, do for GCAN .

Does something like Johnson And Johnson Listerine Strips but infused with Cannabis come to mind? We all know how popular those Strips are.

Johnson And Johnson buys out Listerine brand for 16.6 billion

Think about what GCAN with it's Canadian Cannabis Dream Team along with Our Exclusive World Wide License and Cannabis Oral products will do for GCAN the company and it's shareholders.

Dentists just like Doctors can write RX prescription $GCAN RX products managed by a team with Dental distributors
already in place.


The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.